Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Merck
UBS
Chubb
Citi
Novartis
Argus Health
Baxter
Accenture

Generated: February 21, 2018

DrugPatentWatch Database Preview

Nimodipine - Generic Drug Details

« Back to Dashboard

What are the generic sources for nimodipine and what is the scope of nimodipine patent protection?

Nimodipine
is the generic ingredient in three branded drugs marketed by Bionpharma Inc, Heritage Pharms Inc, Sofgen Pharms, Sun Pharm Inds Inc, Thepharmanetwork Llc, Bayer Pharms, and Arbor Pharms Llc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for nimodipine. Eleven suppliers are listed for this compound.
Pharmacology for nimodipine
Medical Subject Heading (MeSH) Categories for nimodipine

US Patents and Regulatory Information for nimodipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc NIMODIPINE nimodipine CAPSULE;ORAL 077067-001 Apr 17, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sofgen Pharms NIMODIPINE nimodipine CAPSULE;ORAL 201832-001 Jul 24, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Arbor Pharms Llc NYMALIZE nimodipine SOLUTION;ORAL 203340-001 May 10, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Heritage Pharms Inc NIMODIPINE nimodipine CAPSULE;ORAL 077811-001 May 2, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Thepharmanetwork Llc NIMODIPINE nimodipine CAPSULE;ORAL 090103-001 Apr 7, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bionpharma Inc NIMODIPINE nimodipine CAPSULE;ORAL 076740-001 Jan 17, 2008 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for nimodipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Julphar
Healthtrust
Chinese Patent Office
Johnson and Johnson
Cerilliant
Citi
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot